The present application relates to treating and/or preventing prostate cancer, including metastatic and/or castrate-resistant prostate cancer, in a subject in need of treatment, comprising administering a compound of Formula (I),

##STR00001##

or a pharmaceutically acceptable salt, enantiomer, stereoisomer, solvate, polymorph, isotopic derivative, or prodrug thereof, wherein R.sup.1, R.sup.2, R.sup.3, X.sup.1, X.sup.2, X.sup.3, X.sup.4, and n are defined herein.

The present invention relates to an antiparasitic composition comprising an antiparasitic agent and a semifluorinated alkane.

The present invention relates to an antiparasitic composition comprising an antiparasitic agent and a semifluorinated alkane.

Non-human animal models of non-alcoholic fatty liver disease (NAFLD) are provided. Compositions and methods for producing the non-human animal models and uses of the non-human animal models to screen and evaluate agents for treating or preventing NAFLD are also provided.

Non-human animal models of non-alcoholic fatty liver disease (NAFLD) are provided. Compositions and methods for producing the non-human animal models and uses of the non-human animal models to screen and evaluate agents for treating or preventing NAFLD are also provided.

A biomimetic oxygen delivery carrier is provided by employing natural cell membrane as a stabilizer for fluorocarbon nanoemulsions. The resulting formulation exhibits a high capacity for delivering oxygen and can be used to successfully resuscitate subjects in need due to for example hemorrhagic shock. This natural-synthetic platform can alleviate the impact of blood shortages in clinical settings among other uses.

A biomimetic oxygen delivery carrier is provided by employing natural cell membrane as a stabilizer for fluorocarbon nanoemulsions. The resulting formulation exhibits a high capacity for delivering oxygen and can be used to successfully resuscitate subjects in need due to for example hemorrhagic shock. This natural-synthetic platform can alleviate the impact of blood shortages in clinical settings among other uses.

A method of delivering or sequestering anesthetic agents by adsorption of such agents by porous partially fluorinated compounds which display high weight adsorption capacities.

An anesthesia device configured to measure the hydrogen concentration in an anesthesia gas containing a hydrogen gas includes: an anesthesia gas preparation circuit configured to generate anesthesia gas by mixing an air or an oxygen mixture air with a vaporized anesthetic; a closed circuit-type or semi-closed circuit-type respiratory circuit including a gas circulation passage configured to circulate the hydrogen-containing anesthesia gas containing the hydrogen gas and the vaporized anesthetic; and a hydrogen concentration measurement circuit configured to measure the hydrogen concentration in the hydrogen-containing anesthesia gas in the gas circulation passage, wherein the hydrogen concentration measurement circuit includes: an anesthetic removing member having a removability of the vaporized anesthetic in the hydrogen-containing anesthesia gas; and a hydrogen concentration measuring instrument provided on the secondary side of the anesthetic removing member.

An anesthesia device configured to measure the hydrogen concentration in an anesthesia gas containing a hydrogen gas includes: an anesthesia gas preparation circuit configured to generate anesthesia gas by mixing an air or an oxygen mixture air with a vaporized anesthetic; a closed circuit-type or semi-closed circuit-type respiratory circuit including a gas circulation passage configured to circulate the hydrogen-containing anesthesia gas containing the hydrogen gas and the vaporized anesthetic; and a hydrogen concentration measurement circuit configured to measure the hydrogen concentration in the hydrogen-containing anesthesia gas in the gas circulation passage, wherein the hydrogen concentration measurement circuit includes: an anesthetic removing member having a removability of the vaporized anesthetic in the hydrogen-containing anesthesia gas; and a hydrogen concentration measuring instrument provided on the secondary side of the anesthetic removing member.